Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors
Mikael Dolsten, M.D., Ph.D., to its Board of Directors. Dolsten, who served as Pfizer’s chief scientific officer and ...
5 years after pandemic, here's how LouVax may help future fights against infectious disease
As grim a time as it was, those involved at LouVax reflect on the goodwill and selflessness from those who ran the site and passed through it.